CFTR and cystic fibrosis: Delivery of CFTR-upregulating anti-miRNA PNAs can supportnew therapeutic strategies for the treatment of cystic fibrosis.52,53 These results all demonstrate a strategy for formulating PNA intopSiNPs for therapeutic applications in precision medicine.